Q: Could you help explain some of the factors that appeared to negatively impact earnings. ...derivatives, etc. They mentioned that there were also stock options that were not included in the calculations. Is this usual? Thank you kindly for your insight into the results for the last quarter and for 2017.
Q: Hi Folks,
Would you have any particular issues with CCL.B at this time? At around 56 dollars will it act on it's own or just flop around with the general market?
Thanks once again,
Larry
Q: Perhaps you can help solve a small dilemna in our family. My wife believes I should invest in spinmaster and I believe Brp would be better. This is for a TFSA
Which one do you prefer for a long term hold
Please deduct 2 questions one for your answer the other for counselling
Marcel
Q: Has VNR sold off more than you feel the q release would warrant? I mean if you exclude the one time us tax hit then the q looks pretty good... true?
Q: Comments please on the second day of sizeable losses for COV. Hoping to avoid a similar experience I had with a prolonged downward trajectory with CRH. What are your suggestions?
Thank you
Q: Please comment on the impact of Amazon's latest ambition : to be a major hospital supplier on Savaria corp. Savaria stock price has dropped this morning.
Thanks
Q: Can I have your view on the recent purchase of Jarislowsky Fraser Ltd by BNS. It doesn't seem to have affected the BNS stock price very much so wandering if this is going to be a good deal or not? Thanks.
Q: I am in the process of building the Balanced and Growth portfolios, and I would like to take advantage of the recent pullback. I had been waiting for a correction to buy SHOP, but I notice that not only did it not decline much, but that it has recovered extremely quickly. I was under the impression it would be very volatile. Apparently not.
Anyway, could you please help me order in terms of priority to buy the top three or so securities that I don't currently have in the two portfolios:
Balanced: CAE, Celestica, Altus, Parkland, Sun Life, Stella, Sylogist
Growth: Dollarama, Covalon, Photon, Shop, IWO
In terms of best in the sense that they were unfairly punished and therefore have the most potential going forward?
Thanks for always great insight.
Q: Hi,
Covalon is down 19% today after the earnings release. Do you still consider this company a buy and if so would this be a good opportunity to get in.
Q: The 5i Income portfolio could be categorized as an equity income portfolio and I'm wondering how you would quantify the risk of the portfolio relative to the S&P/TSX or other appropriate benchmarks.